13F-HR filed by Meditor Group Ltd
Meditor Group Ltd filed this 13F-HR for the quarter ended 2019-09-30, filed 2019-10-31, with 9 holding rows worth $410,559,000.
- Accession
- 0001062993-19-004099
- Filer
- CIK 1382333
- Filed
- 2019-10-31
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2019
A holdings report, 9 entries on the cover page, a total value of $410,559,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $410,559,000 with VALUE read as thousands by filing date, 13F file number 028-14675. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| EXELIXIS INC COM | 30161Q104 | Stock | 15,001,073 | $265,294,000 | thousands by filing date | |
| ESPERION THERAPEUTICS INC NEW COM | 29664W105 | Stock | 2,679,835 | $98,242,000 | thousands by filing date | |
| ALKERMES PLC | G01767105 | SHS | 892,400 | $17,410,000 | thousands by filing date | |
| ISHARES TR | 46429B598 | MSCI INDIA ETF | 320,000 | $10,742,000 | thousands by filing date | |
| WISDOMTREE TR | 97717W422 | INDIA ERNGS FD | 400,000 | $9,540,000 | thousands by filing date | |
| PROSHARES TR | 74347B383 | ULTRASHRT S&P500 | 115,000 | $3,392,000 | thousands by filing date | |
| INVESCO QQQ TRUST SERIES 1 | 74347B268 | ULTRAPRO SHORT S | 105,000 | $2,727,000 | thousands by filing date | |
| PROSHARES TR | 74348A160 | ULTRAPRO SHORT Q | 71,250 | $2,316,000 | thousands by filing date | |
| CELLDEX THERAPEUTICS INC NEW | 15117B103 | COM | 420,846 | $896,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001062993-19-004099 | this filing | 2019-10-31 | acceptance time not in the bulk data set |